Established in 2007, the company is a one-stop integrated service provider for R&D and commercial production of innovative small-molecule drugs. It is committed to drug discovery, pharmaceutical process research and development, and commercial production of APIs and intermediates. The company is a one-stop comprehensive service provider for new drug development and commercial production. It is committed to drug discovery, pharmaceutical process research and development, and commercial production of API intermediates. The company's main products and businesses: Drug discovery includes pharmaceutical chemistry research, synthetic chemistry research and pharmacokinetics research; process research and development includes process chemistry and process development and CMC research on APIs; commercial production includes customized production of new drugs (CMO) and R&D, production and sales of independent generic drug products.
No Data